Clinical Trials Browser

Recurrence × Thalidomide × Other hematologic neoplasm × Clear all

NCT00083694 2010-07-02

Thalidomide Anti-Angiogenesis Therapy of Relapsed or Refractory Leukemia

Phase 2 Completed

Other hematologic neoplasm

Leukemia, Recurrence